hero section gradient
15 handpicked stocks

Specialty Chemicals: What's Next After BP Castrol Sale

BP's multi-billion dollar sale of its Castrol lubricants division to an infrastructure firm highlights a strategic shift by energy majors to streamline operations. The investment theme focuses on other specialized chemical and industrial companies that may benefit from similar divestitures or become targets for private capital seeking stable, infrastructure-like assets.

Author avatar

Han Tan | Market Analyst

Published on December 27

About This Group of Stocks

1

Our Expert Thinking

BP's recent sale of its Castrol lubricants business for $10.1 billion signals a broader trend where energy majors are divesting stable, cash-generating chemical assets. This creates opportunities for both potential acquisition targets and companies that may pursue similar strategic divestitures to unlock shareholder value.

2

What You Need to Know

This group focuses on specialty chemical and industrial companies with strong brand recognition and consistent demand. These businesses often feature infrastructure-like characteristics that make them attractive to private equity and infrastructure funds seeking defensive investments with steady cash flows.

3

Why These Stocks

These companies were handpicked by professional analysts based on their potential to benefit from the ongoing divestiture trend. The selection includes both energy majors with chemical divisions that could be spun off and pure-play specialty chemical firms that fit the acquisition target profile.

Why You'll Want to Watch These Stocks

🌊

Divestiture Wave Building

BP's £6 billion Castrol sale could trigger a domino effect as other energy majors look to unlock value from their chemical divisions. Early positioning could capture this trend.

💼

Private Capital Interest

Infrastructure funds are actively seeking stable, cash-generating chemical businesses like lubricants and coatings that offer defensive returns in any market environment.

💎

Hidden Value Unlocked

These specialty chemical assets often trade at discounts within larger conglomerates, but strategic sales could reveal their true standalone value to the market.

Frequently Asked Questions